Literature DB >> 16272826

Critical appraisal and review of the Rankin scale and its derivatives.

Peter Wayne New1, Rachelle Buchbinder.   

Abstract

BACKGROUND AND
PURPOSE: Efforts to reduce stroke burden require accurate assessment of outcomes in order to compare treatments. The Rankin Scale and its derivatives, the Modified Rankin Scale and the Oxford Handicap Scale, taken together, are among the most common outcome measures that have been used in stroke research. The aim of this study was to perform a critical appraisal of the clinimetric properties of these scales. It was also planned to review the use of these scales in a selection of articles to illustrate concerns raised by the critical appraisal. SUMMARY OF REVIEW: A literature search was performed using electronic databases to locate relevant articles about the reviewed scales. The scales were appraised using a structured format regarding the following properties: purpose, development, presentation, language, method of administration, content validity, face validity, feasibility, construct validity, reliability, responsiveness, and generalizability. There are concerns in each of the appraised areas regarding the clinimetric properties of these scales.
CONCLUSION: Further work is needed to improve the clinimetric properties of the reviewed scales to ensure that they are more useful tools in determining the outcome of stroke. Alternatively, a newer global outcome scale with improved clinimetric properties may be a better option for future stroke research.

Entities:  

Mesh:

Year:  2005        PMID: 16272826     DOI: 10.1159/000089536

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  24 in total

1.  What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2?

Authors:  N Weisscher; M Vermeulen; Y B Roos; R J de Haan
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

2.  Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA).

Authors:  Jeffrey L Saver; Bogdan Filip; Scott Hamilton; Anna Yanes; Sharon Craig; Michelle Cho; Robin Conwit; Sidney Starkman
Journal:  Stroke       Date:  2010-04-01       Impact factor: 7.914

3.  Association between white matter hyperintensities and stroke in a West African patient population: Evidence from the Stroke Investigative Research and Educational Network study.

Authors:  Jingfei Li; Godwin Ogbole; Benjamin Aribisala; Murtala Affini; Joseph Yaria; Issa Kehinde; Mukaila Rahman; Fakunle Adekunle; Rasaq Banjo; Moyinoluwalogo Faniyan; Rufus Akinyemi; Bruce Ovbiagele; Mayowa Owolabi; Steffen Sammet
Journal:  Neuroimage       Date:  2020-04-07       Impact factor: 6.556

4.  Migraine and functional outcome from ischemic cerebral events in women.

Authors:  Pamela M Rist; Julie E Buring; Carlos S Kase; Markus Schürks; Tobias Kurth
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

5.  Trade-Offs in Quality-of-Life Assessment Between the Modified Rankin Scale and Neuro-QoL Measures.

Authors:  Robert L Askew; Carmen E Capo-Lugo; Rajbeer Sangha; Andrew Naidech; Shyam Prabhakaran
Journal:  Value Health       Date:  2020-09-01       Impact factor: 5.725

6.  Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort study.

Authors:  P M Rist; J E Buring; C S Kase; P M Ridker; T Kurth
Journal:  Eur J Neurol       Date:  2012-10-03       Impact factor: 6.089

7.  Non-steroidal anti-inflammatory drug use and functional outcome from ischemic cerebral events among women.

Authors:  Pamela M Rist; M Maria Glymour; E John Orav; Eunjung Kim; Carlos S Kase; Julie E Buring; Tobias Kurth
Journal:  Eur J Intern Med       Date:  2014-02-11       Impact factor: 4.487

8.  Attitudes of Patients and Relatives Toward Disability and Treatment in Malignant MCA Infarction.

Authors:  Hermann Neugebauer; Matthias Schnabl; Dorothée Lulé; Peter U Heuschmann; Eric Jüttler
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

9.  DESTINY-S: attitudes of physicians toward disability and treatment in malignant MCA infarction.

Authors:  Hermann Neugebauer; Claire J Creutzfeldt; J Claude Hemphill; Peter U Heuschmann; Eric Jüttler
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

10.  Tracheostomy after severe ischemic stroke: a population-based study.

Authors:  Brian P Walcott; Hooman Kamel; Brandyn Castro; W Taylor Kimberly; Kevin N Sheth
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-10-06       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.